Diamond-based quantum device could allow more accessible and easier chemical testing.
Researchers have identified a number of autoantibody biomarkers that could lead to the diagnosis of Crohn’s disease by a simple blood test.
Researchers at the Intermountain Medical Center Heart Institute have created a score system, based on an individual’s age and blood test results that could predict their future risk of chronic disease.
Scientists from the Ulsan National Institute of Science and Technology (UNIST; South Korea) have developed a technique to identify cancer biomarkers in urine, which could potentially be used for early cancer screening.
Genetic information from nasal swab combined with patient data could identify those with lung cancer.
Researchers have identified a new biomarker–methylthioadenosine (MTA)–that could predict death in sepsis patients.
Metabolomic profiling could allow identification of cancer subtypes and precision therapy.
Scientists from the University of Albany (NY, USA) have developed a cost-effective detection method for Ebola, allowing for real-time diagnosis from urine samples.
Pharmaceutical Product Development, LLC has secured its renewal of a fifth contract with National Institutes of Health for HIV research support.
A new report has outlined the validation of a new next-generation sequencing assay for genetic mutations in a variety of different tumors.